139 related articles for article (PubMed ID: 33854300)
1. Pelvic Ultrasound Parameters of Long-Acting Depot Formulation of Leuprorelin in the Treatment of Idiopathic Central Precocious Puberty in Girls.
Yang K; Qi RF; Li RM; Zhang Y; Liu JX
Drug Des Devel Ther; 2021; 15():1479-1484. PubMed ID: 33854300
[TBL] [Abstract][Full Text] [Related]
2. Central precocious puberty in girls: internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues.
Jensen AM; Brocks V; Holm K; Laursen EM; Müller J
J Pediatr; 1998 Jan; 132(1):105-8. PubMed ID: 9470009
[TBL] [Abstract][Full Text] [Related]
3. Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty.
Yu HK; Liu X; Chen JK; Wang S; Quan XY
Front Pharmacol; 2019; 10():104. PubMed ID: 30804790
[No Abstract] [Full Text] [Related]
4. [Evaluations of puberty sexual development in girls by intraluminal ultrasound].
Li XD; Yan X; Chen LH; Tang HJ; Shen HM; Zhou YJ
Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1187-9. PubMed ID: 22883007
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of domestic leuprorelin in girls with idiopathic central precocious puberty: a multicenter, randomized, parallel, controlled trial.
Li WJ; Gong CX; Guo MJ; Xing J; Li T; Song WH; Luo XP; Wu D; Liang JP; Cao BY; Gu Y; Su C; Liang XJ; Liu M; Wang R; Li FT
Chin Med J (Engl); 2015 May; 128(10):1314-20. PubMed ID: 25963350
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pelvic ultrasonography in the diagnosis and differentiation of various forms of sexual precocity in girls.
Badouraki M; Christoforidis A; Economou I; Dimitriadis AS; Katzos G
Ultrasound Obstet Gynecol; 2008 Nov; 32(6):819-27. PubMed ID: 18951545
[TBL] [Abstract][Full Text] [Related]
7. Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
Vurallı D; Alikaşifoğlu A; İyigün İ; Canoruç D; Ozon A; Gönç N; Kandemir N
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):37-44. PubMed ID: 31347350
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
Liang Y; Wei H; Zhang JL; Hou L; Luo XP
Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of girls undergoing medical therapy for isosexual precocious puberty.
Ambrosino MM; Hernanz-Schulman M; Genieser NB; Sklar CA; Fefferman NR; David R
J Ultrasound Med; 1994 Jul; 13(7):501-8. PubMed ID: 7933011
[TBL] [Abstract][Full Text] [Related]
10. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of leuprorelin 3-month depot (11.25 mg) for idiopathic central precocious puberty treatment of Chinese girls: a single-center retrospective study.
Huang S; Zhang L; Gao C; Ou H; Hou L; Liu Z; Wang D; Xu Y; Liang L; Meng Z
J Pediatr Endocrinol Metab; 2024 Jan; 37(1):15-20. PubMed ID: 37975727
[TBL] [Abstract][Full Text] [Related]
12. GnRH agonist treatment in girls with precocious puberty does not compromise post-pubertal uterine size.
Ben-Haroush A; Goldberg-Stern H; Phillip M; de Vries L
Hum Reprod; 2007 Mar; 22(3):895-900. PubMed ID: 17172284
[TBL] [Abstract][Full Text] [Related]
13. A diagnostic model of idiopathic central precocious puberty based on transrectal pelvic ultrasound and basal gonadotropin levels.
Yuan B; Pi YL; Zhang YN; Xing P; Chong HM; Zhang HF
J Int Med Res; 2020 Aug; 48(8):300060520935278. PubMed ID: 32762408
[TBL] [Abstract][Full Text] [Related]
14. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
Tao Y; Si C; Li H; Han J; Hou H; Yang M
Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty.
Vuralli D; Ozon ZA; Gonc EN; Alikasifoglu A; Kandemir N
J Pediatr Endocrinol Metab; 2020 Jan; 33(1):99-105. PubMed ID: 31804960
[TBL] [Abstract][Full Text] [Related]
16. Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues.
Aguiar AL; Couto-Silva AC; Vicente EJ; Freitas IC; Cruz T; Adan L
J Pediatr Endocrinol Metab; 2006 Nov; 19(11):1327-34. PubMed ID: 17220061
[TBL] [Abstract][Full Text] [Related]
17. [Long-acting gonadotropin-releasing hormone analogue in treatment of idiopathic central precocious puberty in girls].
Zhu H; Jiang YJ; Liang L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 May; 37(3):295-9. PubMed ID: 18546534
[TBL] [Abstract][Full Text] [Related]
18. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
[TBL] [Abstract][Full Text] [Related]
19. Telomere length is not altered in girls with idiopathic central precocious puberty treated with a GnRH analog - leuprolide acetate.
Furtado CLM; Iannetta R; Ferriani RA; Rosa E Silva ACJS; Martinelli CE; Calado RT; Dos Reis RM
Gynecol Endocrinol; 2020 Dec; 36(12):1119-1123. PubMed ID: 32496827
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty.
Mondkar S; Khadilkar V; Yewale S; Dange N; More C; Khadilkar A
J Pediatr Endocrinol Metab; 2024 Jan; 37(1):62-68. PubMed ID: 38008794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
